跳至主要内容
临床试验/ISRCTN10376144
ISRCTN10376144已完成未知

A randomised controlled trial to evaluate the impact of supportive text messages from GP practices on self-reported symptoms and inhaler adherence in patients with asthma and/or chronic obstructive pulmonary disease who have been prescribed a preventer (daily) inhaler

Accurx0 个研究点目标入组 4,000 人开始时间: 2022年8月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Accurx
入组人数
4,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Willing and able to provide informed consent and comply with the study instructions
  • 2. Male and females age 18 years or older
  • 3. Confirmed diagnosis of asthma and/or COPD as recorded in the patient’s GP medical record
  • 4. Currently prescribed a preventer inhaler
  • 5. Access to a mobile phone
  • 6. Ability to check text messages on phone
  • 7. Ability to read

排除标准

  • 1. Inability to understand the study procedures
  • 2. Inability or reluctance to provide responses to the study questionnaires
  • 3. Inability to receive and respond to text messages

研究者

发起方
Accurx

相似试验